Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in Ukraine

Based on the pivotal trial showing no clinically relevant differences between pegylated interferon α-2b (Peg-α-2b) and α-2a (Peg-α-2a) combined with ribavirin for treatment of chronic hepatitis C virus (HCV) genotype 1 infection in Ukraine, a cost-minimization analysis was performed using a 1 year t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandrik, Olena, Knies, Saskia, Golubovska, Olha, Duda, Oleksandr, Dudar, Larisa, Fedorchenko, Sergiy, Zaliska, Olha, (Hans) Severens, J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter Open 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152959/
https://www.ncbi.nlm.nih.gov/pubmed/28352673
http://dx.doi.org/10.1515/med-2015-0006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152959/
https://www.ncbi.nlm.nih.gov/pubmed/28352673
http://dx.doi.org/10.1515/med-2015-0006

Ejemplares similares